HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Harshal Nandurkar Selected Research

Neoplasms (Cancer)

4/2019A comparison of global coagulation assays between normal controls and patients with thrombocytopenia.
1/2019Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Harshal Nandurkar Research Topics

Disease

5Hemorrhage
04/2018 - 06/2014
4Infections
10/2022 - 05/2004
4Cardiovascular Diseases (Cardiovascular Disease)
07/2022 - 07/2019
3Venous Thromboembolism
03/2022 - 04/2018
3Thrombosis (Thrombus)
04/2018 - 07/2011
3Hematologic Neoplasms (Hematological Malignancy)
03/2015 - 09/2011
2Neoplasms (Cancer)
04/2019 - 01/2019
2Stroke (Strokes)
04/2018 - 06/2014
2Thrombotic Microangiopathies
07/2017 - 07/2015
1COVID-19
10/2022
1Hypertension (High Blood Pressure)
03/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2019
1Splenomegaly
01/2019
1Chronic Hepatitis B
01/2019
1Wounds and Injuries (Trauma)
01/2019
1Polycythemia (Erythrocytosis)
01/2019
1Hepatitis B
01/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Thrombophilia
09/2017
1von Willebrand Diseases (von Willebrand's Disease)
01/2017
1Systemic Scleroderma (Systemic Sclerosis)
12/2016
1Pulmonary Arterial Hypertension
12/2016
1Gastric Antral Vascular Ectasia (Watermelon Stomach)
11/2015
1Multiple Myeloma
07/2015
1Cerebral Hemorrhage
06/2014
1Hematoma
06/2014
1Venous Thrombosis (Deep-Vein Thrombosis)
04/2014
1Pure Red-Cell Aplasia
03/2014
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2014
1Anemia
05/2013
1Myositis (Idiopathic Inflammatory Myopathies)
11/2012
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
11/2012
1Vasculitis (Vasculitides)
11/2012
1Eosinophilia
11/2012
1Hypothermia
07/2011
1Thrombocytopenia (Thrombopenia)
07/2011
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
05/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2009
1Renal Insufficiency (Renal Failure)
04/2009
1Body Weight (Weight, Body)
04/2009
1Multiple Hamartoma Syndrome (Cowden's Disease)
07/2007

Drug/Important Bio-Agent (IBA)

3FibrinIBA
03/2022 - 04/2018
3AnticoagulantsIBA
01/2019 - 12/2016
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
03/2022 - 08/2021
2Biomarkers (Surrogate Marker)IBA
08/2021 - 06/2014
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2012
2ThrombinFDA Link
07/2019 - 04/2018
2Rituximab (Mabthera)FDA Link
05/2010 - 10/2009
1Hemostatics (Antihemorrhagics)IBA
10/2022
1Hormones (Hormone)IBA
07/2022
1Messenger RNA (mRNA)IBA
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1MethyltransferasesIBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2019
1entecavirFDA Link
01/2019
1Surface Antigens (Surface Antigen)IBA
01/2019
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019
1Tenofovir (Viread)FDA Link
01/2019
1Pharmaceutical PreparationsIBA
01/2019
1Protein Tyrosine PhosphatasesIBA
01/2019
1Vitamin KFDA Link
04/2018
1Warfarin (Coumadin)FDA LinkGeneric
09/2017
1Oxycodone (Oxycontin)FDA LinkGeneric
07/2017
1von Willebrand FactorIBA
01/2017
1apixabanIBA
12/2016
1Imatinib Mesylate (Gleevec)FDA Link
11/2015
1Bortezomib (Velcade)FDA Link
07/2015
1src-Family KinasesIBA
03/2015
1Tranexamic Acid (AMCA)FDA Link
06/2014
1vinyltriethoxysilane (VTES)IBA
04/2014
1HematinicsIBA
05/2013
1Anaplastic Lymphoma KinaseIBA
11/2012
1P-SelectinIBA
07/2011
1Adenosine Diphosphate (ADP)IBA
07/2011
1Fibrinogen (Factor I)FDA Link
07/2011
1Purinergic P2 Receptors (ADP Receptor)IBA
07/2011
1P-2 (P 2)IBA
07/2011
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2010
1Vincristine (Oncovin)FDA LinkGeneric
05/2010
1Prednisone (Sone)FDA LinkGeneric
05/2010
1AnthracyclinesIBA
10/2009
1Protein Kinase C betaIBA
10/2009
1LipidsIBA
04/2009
1C-Reactive ProteinIBA
04/2009
1Phospholipids (Phosphatides)FDA LinkGeneric
07/2007
1AcidsIBA
07/2007

Therapy/Procedure

7Therapeutics
03/2022 - 06/2014
5Drug Therapy (Chemotherapy)
04/2019 - 10/2009
1Heterologous Transplantation (Xenotransplantation)
01/2021
1Intravenous Injections
07/2017
1Lab-On-A-Chip Devices
01/2017
1Duration of Therapy
06/2016
1Palliative Care (Palliative Therapy)
09/2011
1Induced Hypothermia
07/2011